Processa Pharmaceuticals (PCSA) P/E (2017 - 2026)
Processa Pharmaceuticals (PCSA) P/E from Oct 10, 2017 to Jul 20, 2026. The TTM Processa Pharmaceuticals (PCSA) P/E is -0.33. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Processa Pharmaceuticals (PCSA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.33 | -26.87% |
| 2025 | -0.46 | -90.22% |
| 2024 | -4.68 | -18.46% |
| 2023 | -5.74 | -71.01% |
| 2022 | -19.80 | -85.21% |
| 2021 | -133.90 | +53.21% |
| 2020 | -87.40 | -94.77% |
| 2019 | -1.67K | +426.08% |
| 2018 | -317.71 | +650.00% |
| 2017 | -42.36 | N/A |
Comparison Processa Pharmaceuticals (PCSA) P/E with competitors
Processa Pharmaceuticals (PCSA) P/E is -0.33.